Top Markets
Coin of the day
ImmunoGen, Inc. ImmunoGen, Inc.

ImmunoGen, Inc.

IMGN
Rank in Stocks #3091
ImmunoGen, Inc. is a clinical-stage biotechnology enterprise that specializes... ImmunoGen, Inc. is a clinical-stage biotechnology enterprise that specializes in the creation of antibody-drug conjugate (ADC) therapies for cancer treatment. A prominent drug in their pipeline is mirvetuximab soravtansine, an ADC designed to target folate-receptor alpha (FRa), which is currently undergoing Phase III clinical trials for patients with platinum-resistant ovarian cancer. Another significant candidate, Pivekimab sunirine, a CD123-targeting ADC, is progressing through Phase II studies for acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Beyond its clinical efforts, the company's preclinical portfolio includes IMGC936, an ADC being co-developed with MacroGenics, Inc., and IMGN151, another anti-FRa therapeutic. ImmunoGen maintains strategic collaborations with a range of key industry players, such as Roche, Amgen/Oxford BioTherapeutics, Bayer HealthCare AG, Eli Lilly and Company, Novartis Institutes for BioMedical Research, Inc., CytomX Therapeutics, Inc., Fusion Pharmaceuticals Inc., Debiopharm International SA, and MacroGenics, Inc. Founded in 1980, ImmunoGen, Inc. is headquartered in Waltham, Massachusetts.
Share Price
$31.23
Last synced: 2024-02-13
Market Cap
$6.24B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade ImmunoGen, Inc. (IMGN)

Category

Stock price history for ImmunoGen, Inc. (IMGN)
Highest end of day price: $30.21 on 2024-02-01

Lowest end of day price: $8.89 on 1989-11-01
Stock price history of ImmunoGen, Inc. from 1989 to 2026
Annual Stock Price Performance
Year Performance
2024 2.21%
2023 489.22%
2022 -28.32%
2021 5.29%
2020 49.08%
2019 -9.93%
2018 -22.03%
2017 260.54%
2016 -86.73%
2015 56.16%
2014 -42.60%
2013 17.48%
2012 6.39%
2011 30.28%
2010 10.33%
2009 104.59%
2008 -8.33%
2007 -18.87%
2006 1.39%
2005 -29.82%
2004 48.39%
2003 53.96%
2002 -80.05%
2001 -26.61%
2000 400.25%
1999 95.33%
1998 131.85%
1997 -63.52%
1996 56.47%
1995 -41.57%
1994 -68.18%
1993 -19.49%
1992 -35.88%
1991 67.74%
1990 29.68%
1989 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$549.78 42.00%
US
$1.05K 48.14%
NL
$146.07 490.64%
US
$121.62 -12.98%
AU
$764.47 6.25%
CH